US 11118183
Modulation of angiopoietin-like 3 expression
granted A61PA61P3/00A61P3/04
Quick answer
US patent 11118183 (Modulation of angiopoietin-like 3 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P3/00, A61P3/04, A61P43/00, A61P9/00